All Posts

Directed Systems receive digital funding to develop pioneering software

Pioneering software that enables anaesthetists to make better decisions for high risk patients during surgery has been awarded InnovateUK funding. Cambridge based Directed Systems has been allocated a Digital Health Technology Catalyst Round 3 Collaborative R&D grant to develop and market their innovative cardiovascular clinical decision assist systems. The company will…

continue

Joined ABHI US Accelerator – Mark Leaning on trade mission in Texas

Twenty-five leading British HealthTech companies and medical institutions will visit Texas this week (25 to 29thNovember 2018) to showcase the latest medical devices, diagnostic software and digitally-enabled technologies. Organised by the Association of British HealthTech Industries (ABHI),companies will meet with hospital system leaders, GPOs, distributors, clinical leaders and procurement teams…

continue

Closed a second round of investment

Directed Systems successfully closed a second round of investment. “Our planned second fundraising round closed successfully in July. This will allow us to continue our ongoing development work and to prepare and submit our first product application to the FDA for US regulatory clearance. This first product to market, currently under FDA…

continue

Innovate UK Grant Secured

Directed Systems has received an Innovate UK award to conduct a feasibility study into the development of digital control systems for cardiovascular management of patients undergoing anesthesia during surgery. This is part of the Innovate UK Digital Health Catalyst programme. “We are delighted to receive this award. It will enable…

continue

Directed Systems Closes First Round of Investment Funding

Directed Systems has successfully closed its first round of investment. This will allow the Company to develop its first cardiovascular support product further, up to the point of readiness for clinical studies. “I am very pleased that we have closed this investment and with the support of our initial shareholders.…

continue

Enabling superior data-driven clinical decisions